Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

Abstract Background Around 30% of patients with inflammatory bowel disease (IBD) are refractory to current IBD drugs or relapse over time. Novel treatments are called for, and low dose Naltrexone (LDN) may provide a safe, easily accessible alternative treatment option for these patients. We investig...

Full description

Bibliographic Details
Main Authors: Mitchell R. K. L. Lie, Janine van der Giessen, Gwenny M. Fuhler, Alison de Lima, Maikel P. Peppelenbosch, Cokkie van der Ent, C. Janneke van der Woude
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Journal of Translational Medicine
Subjects:
Crohn’s disease
Ulcerative colitis
Naltrexone
Endoplasmic reticulum stress
Wound healing
Online Access:http://link.springer.com/article/10.1186/s12967-018-1427-5

Internet

http://link.springer.com/article/10.1186/s12967-018-1427-5

Similar Items